Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Biochemical Pharmacology

• Publication date

  2000-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0006-2952(00)00422-6PMID 11007947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.

  2000cited by this paper
• Mechanism of STAT3 Activation by Insulin-like Growth Factor I Receptor*

  2000cited by this paper
• Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3

  1999cited by this paper
• Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

  1999cited by this paper
• Variation Among Cell Types in the Signaling Pathways by which IGF-I Stimulates Specific Cellular Responses*

  1999cited by this paper
• The IGF-I receptor in cancer research.

  1999cited by this paper
• Negative Regulation of Epidermal Growth Factor Signaling by Selective Proteolytic Mechanisms in the Endosome Mediated by Cathepsin B*

  1999cited by this paper
• Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-I receptor

  1999cited by this paper
• Growth and Differentiation Signals by the Insulin-like Growth Factor 1 Receptor in Hemopoietic Cells Are Mediated through Different Pathways*

  1999cited by this paper
• Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor.

  1998cited by this paper
• Interaction of Janus Kinases JAK-1 and JAK-2 with the Insulin Receptor and the Insulin-Like Growth Factor-1 Receptor.

  1998cited by this paper
• Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor.

  1998cited by this paper
• Role of insulin-like growth factor binding proteins in controlling IGF actions.

  1998cited by this paper
• Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor.

  1998cited by this paper
• Interplay of the Proto-oncogene Proteins CrkL and CrkII in Insulin-like Growth Factor-I Receptor-mediated Signal Transduction*

  1998cited by this paper
• Survival factors and apoptosis.

  1998cited by this paper
• Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth*

  1998cited by this paper
• Control of breast tumor cell growth using a targeted cysteine protease inhibitor.

  1998cited by this paper
• Insulin-like growth factor-I and new opportunities for cancer prevention.

  1998cited by this paper
• Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology.

  1998cited by this paper
• Insulin-like Growth Factor-I Receptor Internalization Regulates Signaling via the Shc/Mitogen-activated Protein Kinase Pathway, but Not the Insulin Receptor Substrate-1 Pathway*

  1998cited by this paper
• Replacement of Tyrosine 1251 in the Carboxyl Terminus of the Insulin-like Growth Factor-I Receptor Disrupts the Actin Cytoskeleton and Inhibits Proliferation and Anchorage-independent Growth*

  1998cited by this paper
• p125Fak Focal Adhesion Kinase Is a Substrate for the Insulin and Insulin-like Growth Factor-I Tyrosine Kinase Receptors*

  1998cited by this paper
• Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

  1998cited by this paper
• Insulin-like growth factor I stimulates tyrosine phosphorylation of p130(Cas), focal adhesion kinase, and paxillin. Role of phosphatidylinositol 3'-kinase and formation of a p130(Cas).Crk complex.

  1998cited by this paper
• Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.

  1998cited by this paper
• The IGF-I receptor in cell growth, transformation and apoptosis.

  1997cited by this paper
• The insulin signalling system and the IRS proteins

  1997cited by this paper
• IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.

  1997cited by this paper
• Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.

  1997cited by this paper
• Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells.

  1997cited by this paper
• Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.

  1996cited by this paper
• Controlling IGF-receptor function: a possible strategy for tumor therapy.

  1996cited by this paper
• Effect of Mutations at Serines 1280–1283 on the Mitogenic and Transforming Activities of the Insulin-like Growth Factor I Receptor (*)

  1996cited by this paper
• Different Effects on Mitogenesis and Transformation of a Mutation at Tyrosine 1251 of the Insulin-like Growth Factor I Receptor (*)

  1995cited by this paper
• Protein modules and signalling networks

  1995cited by this paper
• The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.

  1995cited by this paper
• Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor.

  1995cited by this paper
• Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.

  1995cited by this paper
• The Role of the Tyrosine Kinase Domain of the Insulin-like Growth Factor-I Receptor in Intracellular Signaling, Cellular Proliferation, and Tumorigenesis (*)

  1995cited by this paper
• Insulin‐like growth factor I receptor is required for the mitogenic and transforming activities of the platelet‐derived growth factor receptor

  1995cited by this paper
• Insulin-like Growth Factor-I Stimulates Tyrosine Phosphorylation of Endogenous c-Crk (*)

  1995cited by this paper
• Non-SH2 Domains within Insulin Receptor Substrate-1 and SHC Mediate Their Phosphotyrosine-dependent Interaction with the NPEY Motif of the Insulin-like Growth Factor I Receptor (*)

  1995cited by this paper
• Mutant IGF-I receptors as dominant negatives for growth and transformation.

  1995cited by this paper
• Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor.

  1994cited by this paper
• A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor

  1994cited by this paper
• Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain.

  1994cited by this paper
• Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts.

  1994cited by this paper
• Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver.

  1994cited by this paper
• c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines.

  1994cited by this paper
• Cancer statistics, 1994

  1994cited by this paper
• Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1.

  1994cited by this paper
• Human insulin-like growth factor I receptor internalization. Role of the juxtamembrane domain.

  1994cited by this paper
• The function of GRB2 in linking the insulin receptor to Ras signaling pathways.

  1993cited by this paper
• Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1

  1993cited by this paper
• Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1.

  1993cited by this paper
• The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro.

  1993cited by this paper
• Insulin-like Growth Factors in Health and Disease

  1992cited by this paper
• Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells.

  1992cited by this paper
• Insulin-like growth factors and cancer.

  1992cited by this paper
• NIH conference. Insulin-like growth factors in health and disease.

  1992cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• Insulin-like growth factors and their binding proteins.

  1990cited by this paper
• G1 events and regulation of cell proliferation.

  1989cited by this paper
• Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells.

  1988cited by this paper
• Growth factor receptor tyrosine kinases.

  1988cited by this paper
• The biology of cancer metastasis and implications for therapy.

  1987cited by this paper
• Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.

  1986cited by this paper
• Uptake of insulin and other ligands into receptor-rich endocytic components of target cells: the endosomal apparatus.

  1985cited by this paper
• The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor.

  1982cited by this paper

• Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma

  2022cites this paper
• Identification of a Resistance Mechanism to IGF-IR Targeting in Human Triple Negative MDA-MB-231 Breast Cancer Cells

  2021cites this paper
• Prognostic significance of preoperative haemoglobin A1c level in patients with lung adenocarcinoma.

  2021cites this paper
• Interested in publishing with us ? Contact book

  2019cites this paper
• PYP1-4 peptide from Pyropia yezoensis protects against acetaminophen-induced hepatotoxicity in HepG2 cells

  2019cites this paper
• Molecular Target Therapy against Neuroblastoma

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Title : Insulin-like growth factor 1 inhibits hair cell apoptosis and promotes the cell cycle of supporting cells by activating different downstream cascades after pharmacological hair cell injury in neonatal mice

  2017influential citation
• The Effect of Diabetes Mellitus on Lung Cancer Prognosis

  2016cites this paper
• Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1

  2016cites this paper
• BMs-536924, an aTP-competitive igF-1r/ir inhibitor, decreases viability and migration of temozolomide-resistant glioma cells in vitro and suppresses tumor growth in vivo

  2015cites this paper
• BMS-536924, an ATP-competitive IGF-1R/IR inhibitor, decreases viability and migration of temozolomide-resistant glioma cells in vitro and suppresses tumor growth in vivo

  2015cites this paper
• The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis

  2015cites this paper
• Insulin-like growth factor 1 induces the transcription of Gap43 and Ntn1 during hair cell protection in the neonatal murine cochlea.

  2014cites this paper
• Functional Analysis of Pleckstrin-2 Gene in Lung Cancer Cells

  2014cites this paper
• Recent advancements in small molecule inhibitors of insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase as anticancer agents.

  2013cites this paper
• Plant Sterols as Anticancer Nutrients: Evidence for Their Role in Breast Cancer

  2013influential citation
• Insulin-like growth factor 1 inhibits hair cell apoptosis and promotes the cell cycle of supporting cells by activating different downstream cascades after pharmacological hair cell injury in neonatal mice.

  2013influential citation
• Heterogeneity of neuroblastoma cell lines in insulin‐like growth factor 1 receptor/Akt pathway‐mediated cell proliferative responses

  2013cites this paper
• Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation

  2013cites this paper
• Obesity and Multiple Myeloma

  2012cites this paper
• Ritmicidad biológica de la secreción de ghrelina, GH e IGF-1, y su regulación por la alimentación

  2012cites this paper
• Increased expression of insulin‐like growth factor‐1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma

  2012cites this paper
• Epidermal growth factor receptor and K‐Ras mutations and resistance of lung cancer to insulin‐like growth factor 1 receptor tyrosine kinase inhibitors

  2012cites this paper
• A multiplicity of anti‐invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer

  2012cites this paper
• Insulin-like growth factor-1 boosts the developing process of condylar hyperplasia by stimulating chondrocytes proliferation.

  2012cites this paper
• Caveolin‐1 is essential for metformin inhibitory effect on IGF1 action in non‐small‐cell lung cancer cells

  2012cites this paper
• Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?

  2011cites this paper
• Regulation of receptor for activated C kinase 1 protein by the von Hippel–Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness

  2011cites this paper
• Estudio del valor patogénico de la expresión y ruta de señalización de KIT e IGF1R en Sarcoma de Ewing: ¿nuevas posibles dianas terapeúticas?

  2011cites this paper
• Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.

  2011cites this paper
• Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells.

  2011cites this paper
• Ginsenoside Rp1 from Panax ginseng Exhibits Anti-cancer Activity by Down-regulation of the IGF-1R/Akt Pathway in Breast Cancer Cells

  2011cites this paper
• Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ

  2011cites this paper
• Roles of protein kinase B/Akt in lung cancer.

  2010cites this paper
• Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.

  2010cites this paper
• Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.

  2010cites this paper
• Insulin‐like growth factor‐1 receptor and phosphorylated AKT‐serine 473 expression in 132 resected thymomas and thymic carcinomas

  2010cites this paper
• Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.

  2010cites this paper
• Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001

  2009cites this paper
• Growth factor receptors signaling in glioblastoma cells: therapeutic implications

  2009cites this paper
• Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells

  2009cites this paper
• Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells

  2008cites this paper
• The insulin‐like growth factor‐I receptor inhibitor NVP‐AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells

  2008cites this paper
• Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor.

  2008cites this paper
• Clinical Significance of Insulin-Like Growth Factor Type 1 Receptor and Epidermal Growth Factor Receptor in Patients with Advanced Gastric Cancer

  2008cites this paper
• Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer

  2008cites this paper
• Functional analysis of IGFBP-2 overexpression in mouse liver myofibroblasts

  2008cites this paper
• Screening of Natural Products for the Development of Anti-cancer Agents in Non-Small Cell Lung Cancer (NSCLC)

  2008cites this paper
• Anti-apoptotic actions of insulin-like growth factors: lessons from development and implications in neoplastic cell transformation.

  2007cites this paper
• [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology].

  2007cites this paper
• RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205.

  2007cites this paper
• Progress in the development of small molecule inhibitors of insulin-like growth factor-1 receptor kinase

  2007cites this paper
• Regulation Of Membrane-Type 1 Matrix Metalloproteinase In Prostate Cancer

  2007cites this paper
• Inhibition of hepatocellular carcinoma growth by antisense oligonucleotides to type I insulin‐like growth factor receptor in vitro and in an orthotopic model

  2007cites this paper
• Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro

  2007cites this paper
• Suppression of type 1 Insulin-like growth factor receptor expression by small interfering RNA inhibits A549 human lung cancer cell invasion in vitro and metastasis in xenograft nude mice.

  2007cites this paper
• RAV 12 Accelerates the Desensitization of Akt / PKB Pathway of Insulin-like Growth Factor I Receptor Signaling in COLO 205

  2007cites this paper
• ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents.

  2007cites this paper
• Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor–independent urokinase-type plasminogen activator inhibition

  2006cites this paper
• The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence

  2006cites this paper
• Targeting the insulin-like growth factor axis as a cancer therapy.

  2006cites this paper
• Early effects of imatinib mesylate on the expression of insulin‐like growth factor binding protein‐3 and positron emission tomography in patients with gastrointestinal stromal tumor

  2006cites this paper
• Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.

  2006cites this paper
• Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib.

  2006cites this paper
• inhibition independent urokinase-type plasminogen activator − factor protein-3 in lung cancer is mediated by insulin-like growth Antimetastatic activity of insulin-like growth factor binding

  2006cites this paper
• IGF-1R inhibition : A tool for functional studies of insulin-like growth factor family in malignant cells

  2006cites this paper
• The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection

  2006cites this paper
• Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib

  2006cites this paper
• Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.

  2005influential citation
• Synergism Induced by Combination of Farnesyl Transferase Inhibitor SCH66336 and Insulin like-Growth Factor Binding Protein-3 in apoptosis of Non-Small Cell Lung Cancer Cell lines

  2005cites this paper
• Small-Molecule Receptor Tyrosine Kinase Inhibitors in Targeted Cancer Therapy

  2005cites this paper
• Blockade of Paracrine Supply of Insulin-Like Growth Factors Using Neutralizing Antibodies Suppresses the Liver Metastasis of Human Colorectal Cancers

  2005cites this paper
• Metastasis of Human Colorectal Cancers Using Neutralizing Antibodies Suppresses the Liver Blockade of Paracrine Supply of Insulin-Like Growth Factors

  2005cites this paper
• Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.

  2005cites this paper
• Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation.

  2005cites this paper
• Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.

  2005cites this paper
• Role of insulin-like growth factor 1 receptor signalling in cancer

  2005cites this paper
• In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate Tumors

  2005cites this paper
• Response of Non–Small Cell Lung Cancer Cells to the Inhibitors of Phosphatidylinositol 3-Kinase/Akt- and MAPK Kinase 4/c-Jun NH2-Terminal Kinase Pathways: An Effective Therapeutic Strategy for Lung Cancer

  2005cites this paper
• Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells.

  2004cites this paper
• Loss of Tumorigenicity and Metastatic Potential in Carcinoma Cells Expressing the Extracellular Domain of the Type 1 Insulin-Like Growth Factor Receptor

  2004cites this paper
• Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells

  2004cites this paper
• Endocrine aspects of cancer gene therapy.

  2004cites this paper
• The IGF-1 Receptor in Cell Survival: Signalling and Regulation

  2004cites this paper
• The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway

  2004cites this paper
• Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.

  2004cites this paper
• A Dominant Negative Type I Insulin-like Growth Factor Receptor Inhibits Metastasis of Human Cancer Cells*

  2004cites this paper
• Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor

  2004cites this paper
• The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?

  2003cites this paper
• Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor

  2003cites this paper
• The role of receptor tyrosine kinase inhibition in treating gastrointestinal malignancy

  2003cites this paper
• The Role of the IGF-I Receptor in the Regulation of Matrix Metalloproteinases, Tumor Invasion and Metastasis

  2003cites this paper
• Development of New Insulin-like Growth Factor-1 Receptor Kinase Inhibitors Using Catechol Mimics*

  2003cites this paper
• The Insulin-like Growth Factors and Insulin-signalling Systems: An Appealing Target for Breast Cancer Therapy?

  2003cites this paper
• Insulin-like growth factor-I receptor and PTEN protein expression in endometrial carcinoma. Correlation with bax and bcl-2 expression, microsatellite instability status, and outcome.

  2003cites this paper
• Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling

  2003cites this paper
• Antisense therapeutics: from theory to clinical practice.

  2003cites this paper
• Growth of Non-Small Cell Lung Cancer Insulin-like Growth Factor Binding Protein-3 Inhibits the Updated Version

  2002cites this paper
• Bone growth factors in maxillofacial skeletal reconstruction

  2002cites this paper